Scientists from Oregon Health and Science University reported on Wednesday in the scientific journal Cell that they had created embryonic stem cells from a cloned human embryo. This is the first time that human stem cells have been produced using nuclear transfer, a cloning technique in which the nucleus of one person’s cell is transferred into an egg that has had its nucleus removed. The technique could be used to create patient-specific human embryonic stem cells, which could be used to study genetic diseases, aid drug development, and for therapeutic transplantation back into a patient.
Patient-specific stem cells can also be created by “deprogramming” adult cells such as skin cells into a stem-cell state (see “Medicine’s New Toolbox”). The resulting induced pluripotent stem cells are widely used by researchers. But some studies suggest that genetic and molecular abnormalities may be more common in the induced pluripotent stem cells than in cloned embryonic stem cells and it’s not yet clear how well induced pluripotent stem cells will be at creating the diversity of cell types in the human body.
In the Wednesday report, Shoukhrat Mitalipov and colleagues write that past attempts at creating cloned embryonic stem cells were troubled by developmental arrests in the embryos created by nuclear transfer. According to Nature,the investigators tested and tweaked cloning techniques on “more than 1,000 monkey eggs before moving on to human cells” and finding the right combination of methods.
The resulting technique makes use of the outer covering of a virus that triggers cell fusion, an electric pulse to activate development of the egg-nucleus hybrid, and a bit of caffeine to steady embryonic development. The researchers used the cloned embryonic stem cells to produce different cell types, including heart cells capable of beating. The embryos described in the paper were grown for a maximum of seven days.
Some may worry that scientists can now clone humans, but according to an OHSU release, Mitalipov has tried for several years to produce a monkey from nuclear-transfer embryos without success. As reported by National Public Radio: “The procedures we developed actually are very efficient to make stem cells, but it’s unlikely that this will be very useful for kind of reproductive cloning,” Mitalipov says.
Meet Altos Labs, Silicon Valley’s latest wild bet on living forever
Funders of a deep-pocketed new "rejuvenation" startup are said to include Jeff Bezos and Yuri Milner.
Tonga’s volcano blast cut it off from the world. Here’s what it will take to get it reconnected.
The world is anxiously awaiting news from the island—but on top of the physical destruction, the eruption has disconnected it from the internet.
Going bald? Lab-grown hair cells could be on the way
These biotech companies are reprogramming cells to treat baldness, but it’s still early days.
A horrifying new AI app swaps women into porn videos with a click
Deepfake researchers have long feared the day this would arrive.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.